MDG1 — Medigene AG Balance Sheet
0.000.00%
- €2.51m
- -€8.97m
- €6.03m
Annual balance sheet for Medigene AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 34.7 | 30 | 22.4 | 33.2 | 16.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.469 | 1.58 | 1.04 | 3.24 | 1.03 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 57.7 | 32.7 | 24.2 | 37.3 | 18.1 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.82 | 6.88 | 4.9 | 4.39 | 3.44 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 109 | 74.8 | 59.5 | 51.7 | 31.7 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10.2 | 10.1 | 8.03 | 7.42 | 7.18 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 27.4 | 21.6 | 14.7 | 14.7 | 10.7 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 81.8 | 53.2 | 44.8 | 37 | 21.1 |
Total Liabilities & Shareholders' Equity | 109 | 74.8 | 59.5 | 51.7 | 31.7 |
Total Common Shares Outstanding |